Survival of deleterious infections depends significantly on how much stress the affected organism can tolerate. In this issue, Weis et al. find that mice can survive sepsis by maintaining normoglycemia through ferritin's capacity to inactivate Fe 2+ ions that otherwise induce free radicals impacting gluconeogenesis in the liver.
Animals and plants use three strategies to deal with pathogens: avoidance, resistance, and tolerance (ART). Because animals are more mobile than plants and possess specialized mobile defense cells, they rely significantly on avoidance of pathogens and resistance to them. In contrast, tolerance is a very prominent strategy in plants, so it is not surprising that the concept of tolerance of pathogens originated from the studies of plants (Schafer, 1971) . However, the role of tolerance in host-pathogen interactions in animals and humans is steadily becoming better appreciated (Medzhitov et al., 2012; Rå berg et al., 2009) . Tolerance is usually defined as the ability to maintain health (fitness) in the presence of a pathogen, without affecting the pathogen burden. The mechanisms of tolerance aim to reduce tissue damage that is due to either the direct effect of pathogens on tissue integrity and/or metabolic regulation or the indirect effects of the resistance mechanisms causing collateral damage. Examples of tolerance of pathogens are widely known to the public: e.g., the case of Mary Mallon, or ''typhoid Mary,'' a cook who was an asymptomatic carrier of Salmonella typhi, which caused severe illness in people consuming the dishes she prepared, or the mild disease caused by malaria plasmodium in people suffering sickle-cell anemia (SCA). The reason for Ms. Mallon's tolerance of Salmonella will probably never be known, but in the case of SCA, at least one tolerance mechanism has been elucidated. In malaria-infected cells in individuals with SCA, the abnormal hemoglobin induces a master-regulator of the oxidative stress response, the transcription factor NF-E2-related factor 2 (Nrf2), which stimulates the expression of heme oxygenase-1 (HO-1) and the production of carbon monoxide (CO), which inactivates circulating heme and reduces the severity of the disease (Ferreira et al., 2011) .
Heme is an iron-containing porphyrin and is used as a prosthetic group by hemoproteins including hemoglobin. Free heme serves as a donor of divalent iron (Fe 2+ ) that is highly cytotoxic, whereas trivalent iron (Fe 3+ ) is not. In this issue of Cell, Weis et al. (2017) describe a previously unappreciated mechanism of tolerance to sepsis that, at its core, also requires inactivation of Fe 2+ ions (see Figure 1 ). Sepsis is a severe condition that develops as a reaction to invasive infections and manifests as a loss of regulation of systemic and local inflammatory reactions, as well as a loss of control over essential metabolic processes. One of the clinical features of sepsis is increased hemolysis (destruction of erythrocytes), which can be caused by the direct effects of pathogen-made hemolysins, antibodies+complement recognition of bacterial products bound to erythrocyte membranes, disseminated intravascular coagulation, or aggravation of pre-existing conditions such as a hemoglobinopathy. Free heme is removed by HO-1, but the divalent iron liberated in the process causes the production of reactive radicals by a process termed the Fenton reaction. In the Fenton reaction, Fe 2+ interacts with hydrogen peroxide to produce Fe 3+ and a highly reactive hydroxyl radical that engages in secondary reactions. To prevent the toxic effects of free reactive radicals, the iron ions are removed by ferritin protein complexes that also have ferroxidase activity and oxidize Fe 2+ to Fe 3+ . Ferritin has been previously found to contribute to disease tolerance by reducing the damaging effects of ROS in malaria infections (Gozzelino et al., 2012) and in genetically modified plants expressing ferritin ectopically (Deá k et al., 1999 (G6pc1 D/D ) were more susceptible to CLP-induced mortality, and injection of these mice with free heme led to severe hypoglycemia. Thus far, it appeared that in the CLP model of sepsis, free heme was decreasing G6PC1 expression, reducing the liver's capacity for gluconeogenesis and glycogenolysis and leading to elevated mortality. In the next series of experiments, the authors showed that ferritin lacking ferroxidase activity does not restore either G6PC1 expression or blood glucose levels. G6PC1 expression could be restored in heme-exposed cells (hepatocytic cell line) by an iron chelator, suggesting that the role of ferritin is to remove Fe 2+ and indirectly reduce the production of free radicals. Indeed, this idea was confirmed by restoration of tolerance to sepsis by injection of antioxidants and of iron-free but not iron-bound ferritin. Importantly, antioxidants did not produce their positive effect in G6pc1 D/D mice, confirming the important contribution of ferritin to the tolerance of polymicrobial infections through induction of gluconeogenesis. This work is a great example of a logical and persistent effort to untangle the chain of events leading to the establishment of tolerance to systemic microbial challenge. However, several interesting questions remain to be addressed. Whereas transferrin expression is regulated at the level of translation by iron sensing, the regulation of G6PC1 expression is more complicated: in addition to repression by reactive oxygen species (ROS), G6PC1 can be repressed due to heme signaling through Toll-like receptor 4 (TLR4). The relative contributions and details of the pathways involved remain to be elucidated. The role of ferritin expression by macrophages in the establishment of tolerance also remains unknown. One could also wonder what role the host's microbial environment plays in the regulation of tolerance of infection: it has been long known that LPS-induced lethality is very low in germ-free animals (Jensen et al., 1963) .
Another very important result is the clinically translatable part of the work: sepsis can be better tolerated with injections of iron-free transferrin, antioxidants, or glucose. The question is, of course, how to get it right? In a recent publication (Wang et al., 2016 ), Medzhitov and colleagues have shown that the survival of mice with systemic Listeriosis or systemic treatment with LPS worsened when their hypoglycemia was countered with glucose injection because glucose promoted neurotoxicity by ROS. In contrast, virally-infected mice benefited from glucose injections, which reduced the neuronal ER-stress triggered by type I interferon. The Wang et al. study supported the concept that adaptive tolerance mechanisms are linked to the type of microbial challenge that the host is facing. In agreement with that, Weis et al. also found that recovery from hypoglycemia induced by LPS was G6PC1-dependent, whereas poly(I:C)-induced hypoglycemia was not. Wang et al. (2016) found that fasting metabolism is protective from sepsis and that protection is suppressed by exogenously delivered glucose. Here, Weis et al. (2017) have used FTH-and G6PC1-negative mice to discover that mice have to maintain minimal glucose levels via gluconeogenesis. Thus, upper -containing heme. HO-1 (heme oxygenase-1) inactivates heme, preventing its cytotoxicity, but Fe 2+ induces the production of reactive radicals by the Fenton chemistry (shown in simplified form). The radicals downregulate the glucose-6-phosphatase (G6Pase) required for gluconeogenesis in the liver and cause lethal hypoglycemia. Heme may also contribute to G6Pase inhibition by signaling through Toll-like receptor 4 (TLR4). (B) Ferritin jails Fe 2+ ions, leading to an increase in G6Pase expression and normalization of blood glucose levels. (C) The majority of wild-type mice survive either the cecal ligation and puncture (CLP) procedure or peritoneal contamination and infection (PCI) with human microbiota (red curve). Mice lacking the ferritin subunit FTH or the G6Pase subunit G6PC1 die from the same challenges (black curve). FTH-negative mice can be saved by injection of iron-free ferritin, glucose, or antioxidants, whereas antioxidants cannot help G6Pase-negative mice, suggesting that the scavenging of Fe 2+ iron by ferritin is upstream of the gluconeogenesis that requires G6Pase. The key feature of transferrin-mediated normoglycemia is that it does not affect the microbial burden in the internal organs, strongly suggesting that the health improvement is due to enhanced tolerance of infection. and lower boundaries of glucose homeostasis must be protected by reduced intake (anorexia) and by endogenous hepatic glucose production (gluconeogenesis). The levels of glucose that benefit the host must be regulated just right. One spoonful, perhaps. The role of microglia in neurodegenerative diseases has been controversial. In this issue, KerenShaul et al. identify a unique population of disease-associated microglia (DAM) that develop in two steps and may help to restrict damage in Alzheimer and related diseases.
DAMed in (Trem) 2 Steps
In the early 1920s, Pio del Rio Hortega identified microglia and their phenotypes in different pathologies. Thereafter, progress in understanding of microglial development and function was gradual until a seminal study identified primordial macrophages as precursors of microglia, whose arrival in the central nervous system coincides with development of the blood vasculature (Ginhoux et al., 2010) . Subsequent studies confirmed that under physiological conditions peripheral monocytes do not engraft the brain parenchyma, but rather that throughout life the microglial pool is maintained by self-proliferation (Goldmann et al., 2013) . After CNS injury or neuroinflammation (as in experimental autoimmune encephalomyelitis), peripheral monocytes invade the parenchyma but do not persist there. The role of microglia versus engrafted peripheral monocytes in Alzheimer's disease (AD) (Boissonneault et al., 2009) , amyotrophic lateral sclerosis (ALS) (Butovsky et al., 2012) , Rett syndrome (Derecki et al., 2012), and other neurodegenerative diseases is still under debate, in part because of how heterogeneous these populations could be. To begin to understand the diversity of immune cells in the brain and how they may affect diseases, KerenShaul et al. (Keren-Shaul et al., 2017) in this issue of Cell use single-cell transcriptomics, to comprehensively map all immune populations in the brains and meninges of normal mice and animal models of Alzheimer's-like pathology.
One of the problems with previous studies is that isolation of microglia has been based on only two markers, CD45 and CD11b. Whereas meaningful data can be obtained from microglia isolated from normal brains, the characteristic heterogeneity of microglia in diseased brains precludes accurate isolation of their subtypes based on so few markers, since possible microglial subpopulations associated with a particular pathology would be missed. This is exactly what the current Cell paper shows. The authors exploit single-cell genomics to better understand which microglial subtypes are associated with AD and other pathologies. In their unbiased analysis of thousands of cells, they happen upon two unique microglial populations found in the brain cortex of AD mice, but not in healthy mice (wild-type or AD mice in an early phase of disease) or in brain areas less affected by amyloid pathology. They call these cells diseaseassociated microglia (DAM).
The role of the Trem2 protein, one of the major risk factors for AD, much as the role of microglia in animal AD models, has also been hotly debated (Ulrich et al., 2017) . Keren-Shaul et al. new data show that as disease progresses, microglia evolve into DAM in a two-step process. In the first step, which is Trem2-independent, the homeostatic microglial signature is lost, and in the second, Trem2-dependent step, the cells acquire a phenotype associated with phagocytosis and lipid metabolism (Figure 1) . It remains to be tested whether DAM depletion affects disease initiation
